Definitions
Precisely define terms such as Invention, Work Product, Confidential Information, and Prior IP to avoid ambiguity during enforcement or assignment disputes.
A clear IP Policy Agreement prevents ownership disputes, ensures enforceable assignment of rights, protects confidential information, and sets expectations for inventorship and royalties. It reduces litigation risk and preserves the organization’s ability to exploit, license, and defend its IP while documenting consent and intent in compliance with ESIGN/UETA.
Precisely define terms such as Invention, Work Product, Confidential Information, and Prior IP to avoid ambiguity during enforcement or assignment disputes.
State that all relevant IP created within scope of employment or engagement is assigned to the company; include language for inventions conceived on company time or using company resources.
Specify any retained rights, open-source obligations, and permitted personal use; include scope, territory, duration, and sublicensing rules where applicable.
Require prompt disclosure of inventions and cooperation in patent prosecution, including execution of assignment instruments and filing assistance as needed.
Tie confidentiality obligations to IP protections; describe permitted disclosures, return of materials, and survival of confidentiality after termination.
Describe injunctive relief, damages, indemnity for third-party claims, and dispute resolution methods such as arbitration or chosen jurisdiction.
Organizations use an IP Policy Agreement when hiring staff, engaging contractors, or collaborating with external parties to ensure ownership and licensing terms are set in advance.
Use the agreement at onboarding, contract initiation, or before collaboration milestones to avoid retroactive disputes and ensure enforceable documentation.
In-house or outside counsel drafts and reviews the agreement to ensure assignment language is enforceable, coordinates inventor disclosures, and advises on jurisdictional issues such as state variations in UETA/ESRA treatment.
Employees, contractors, consultants, or collaborators who must understand obligations, provide inventor disclosures, and sign to record consent to assignment, license terms, and confidentiality obligations.
| Field | Configuration |
|---|---|
| Signature Placement | Place signature, date, and title fields for each signer in order. |
| Authentication | Use email plus optional SMS code or KBA for higher assurance. |
| Signing Order | Set sequential signing when approvals must follow a defined chain. |
| Retention | Enable copy distribution and centralized storage for audit purposes. |
Ensure the platform you use supports required formats, authentication methods, and secure storage for executed IP agreements.
Preserve the audit trail, signed copies, and any notarization artifacts in a secure repository accessible to legal and HR teams.
When assignment and confidentiality obligations begin; use MM/DD/YYYY.
Timeframe for inventor disclosures after conception or discovery.
Period for legal or management to review and accept assignment.
Deadline for providing notice to inventors before external filing begins.
Period required to modify or terminate license provisions, if allowed.
A small investment firm standardized IP assignment language to protect portfolio innovations.
An enterprise aligned assignment clauses with ERP records and approvals.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies by plan | Varies by plan | Varies by plan | Varies by plan |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |